News
Like in the STRIDE study of PAD, GLP-1s improved outcomes, but more work is needed to clarify who may benefit most.
A new study published in The Lancet journal showed that patients with type 2 diabetes and symptomatic peripheral arterial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback